Mesa Laboratories, Inc.
MLAB
$92.77
$1.571.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 316.59% | -27.77% | 39.96% | 97.21% | -179.21% |
| Total Depreciation and Amortization | 3.97% | -3.61% | 9.00% | 19.09% | -39.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.16% | 199.94% | -138.38% | -98.97% | 2,171.67% |
| Change in Net Operating Assets | 25.85% | 9.31% | -2,252.37% | 13.14% | 3,559.22% |
| Cash from Operations | 3.45% | 55.99% | -82.38% | -1.69% | 57.17% |
| Capital Expenditure | 9.96% | 38.93% | -13.24% | -41.50% | 27.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 9.96% | 38.93% | -13.24% | -336.38% | 98.99% |
| Total Debt Issued | -- | -- | -85.71% | -- | -100.00% |
| Total Debt Repaid | 7.96% | -1,290.84% | 90.82% | -55.98% | -4.87% |
| Issuance of Common Stock | -- | -- | -- | 638.55% | -- |
| Repurchase of Common Stock | -- | -- | -- | -21.84% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.73% | -1.85% | -1.16% | -0.69% | -0.81% |
| Other Financing Activities | -1,170.00% | -83.71% | -937.73% | 531.16% | 106.90% |
| Cash from Financing | 4.88% | 8.44% | 10.53% | -25.21% | -116.91% |
| Foreign Exchange rate Adjustments | 177.07% | -110.48% | 957.71% | 333.16% | -138.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.22% | 79.27% | -2,441.86% | -36,250.00% | 189.53% |